نتائج البحث

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

• Authors : National Cancer Institute (NCI)

• Source: Multi-Center Phase II Randomized Controlled Trial of Naïve T Cell Depletion for Prevention of Chronic Graft-Versus-Host

تفاصيل العنوان

Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease

• Authors : Sanofi

• Source: Randomized Phase II Study of Belumosudil vs. Placebo for Preemptive Treatment of Chronic Graft Versus Host

تفاصيل العنوان

Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study

• Authors : National Cancer Institute (NCI)

• Source: Predicting the Quality of Response to Specific Treatments (PQRST)

تفاصيل العنوان

Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease

• Authors : AstraZeneca

• Source: Acalabrutinib for Chronic Graft-Versus-Host Disease

تفاصيل العنوان

Fecal Microbiota Transplant and Dietary Fiber Supplementation for the Treatment of Gut Graft Versus Host Disease

• Authors : National Heart, Lung, and Blood Institute (NHLBI)

• Source: A Randomized, Controlled, Phase I Study of Fecal Microbiota Transplant and Dietary Fiber Supplementation in Graft Versus Host

تفاصيل العنوان

Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation

• Source: Fecal Microbiota Transplantation to Prevent Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic

تفاصيل العنوان

Improving Outcomes Assessment in Chronic GVHD

• Authors : University of Minnesota; Stanford University; Dana-Farber Cancer Institute

• Source: Improving Outcomes Assessment in Chronic GVHDInamoto Y, Martin PJ, Onstad LE, Cheng GS, Williams KM, Pusic I, Ho VT, Arora M, Pidala J, Flowers MED, Gooley TA, Lawler RL, Hansen JA, Lee SJ.

تفاصيل العنوان

Chronic GVHD Response Measures Validation

• Source: Chronic GVHD Response Measures ValidationInamoto Y, Martin PJ, Onstad LE, Cheng GS, Williams KM, Pusic I, Ho VT, Arora M, Pidala J, Flowers MED, Gooley TA, Lawler RL, Hansen JA, Lee SJ.

تفاصيل العنوان

Glasdegib for Chronic Graft-Versus-Host Disease

• Authors : Pfizer; Stephanie Lee, Professor

• Source: A Single-Arm, Open-Label, Phase I/II Study of Glasdegib for Sclerotic Chronic Graft-Vs-Host

تفاصيل العنوان

Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD

• Authors : National Cancer Institute (NCI)

• Source: A Multi-center Phase II Study of Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHDBleakley M, Sehgal A, Seropian S, Biernacki

تفاصيل العنوان